Lyre's

Lyre's, based in Australia, specializes in crafting non-alcoholic spirits that offer sophisticated alternatives for consumers seeking flavorful options without alcohol. Founded in 2019 in Sydney, Australia, Lyre's produces non-alcoholic spirits that replicate traditional alcoholic beverages. The company has closed 6 deals, with its latest funding round raising GBP 18. 000 mn on August 21, 2023, from investors including D Squared Capital and Morgan Creek Capital Management.

The CEO, Mark Livings, co-founded the company alongside Carl Hartmann and Paul Gloster. Lyre's offers a diverse range of non-alcoholic spirits and alternative beverages designed for consumers seeking sophisticated drink options without alcohol. Their core offerings include various spirit alternatives that replicate the taste and experience of traditional alcoholic beverages, making them suitable for social and culinary uses. The company targets major markets including Australia, the United Kingdom, and parts of North America, focusing on health-conscious individuals and those participating in sober events.

By combining innovative ingredients and complex flavor profiles, Lyre's meets the needs of a demographic seeking flavorful alternatives without compromising social experiences. Lyre's generates revenue through direct-to-consumer sales and partnerships with retailers and hospitality venues. Their transaction structure involves wholesale arrangements with liquor stores and bars, as well as online direct sales. Each product is marketed as a premium alternative, appealing to a customer base willing to invest in high-quality non-alcoholic options.

Pricing reflects the brand's market positioning, catering to individuals seeking a sophisticated drinking experience. In August 2023, Lyre's secured additional venture funding from Futurecraft Ventures to support its strategic initiatives. The company plans to expand its product line with new non-alcoholic offerings and aims to penetrate emerging markets across Europe and Asia by the end of 2024. Recent funding will be utilized to enhance product development and market entry strategies.